Li Shimeng - Net Worth and Insider Trading

Li Shimeng Net Worth

The estimated net worth of Li Shimeng is at least $15.5 Billion dollars as of 2025-04-03. Li Shimeng is the of Simcere Pharmaceutical Group Ltd and owns about 1,787,828,668 shares of Simcere Pharmaceutical Group Ltd (HKSE:02096) stock worth over $15.5 Billion. Details can be seen in Li Shimeng's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Li Shimeng has not made any transactions after 2025-01-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Li Shimeng

To

Li Shimeng Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Li Shimeng owns 1 companies in total, including Simcere Pharmaceutical Group Ltd (HKSE:02096) .

Click here to see the complete history of Li Shimeng’s form 4 insider trades.

Insider Ownership Summary of Li Shimeng

Ticker Comapny Transaction Date Type of Owner
HKSE:02096 Simcere Pharmaceutical Group Ltd 2025-01-23 2501 Other

Li Shimeng Latest Holdings Summary

Li Shimeng currently owns a total of 1 stock. Li Shimeng owns 1,787,828,668 shares of Simcere Pharmaceutical Group Ltd (HKSE:02096) as of January 23, 2025, with a value of $15.5 Billion.

Latest Holdings of Li Shimeng

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02096 Simcere Pharmaceutical Group Ltd 2025-01-23 1,787,828,668 8.66 15,482,596,265

Holding Weightings of Li Shimeng


Li Shimeng Form 4 Trading Tracker

According to the SEC Form 4 filings, Li Shimeng has made a total of 40 transactions in Simcere Pharmaceutical Group Ltd (HKSE:02096) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Simcere Pharmaceutical Group Ltd is the sale of 0 shares on January 23, 2025, which brought Li Shimeng around $0.

Insider Trading History of Li Shimeng

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Li Shimeng Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Li Shimeng Ownership Network

Ownership Network List of Li Shimeng

No Data

Ownership Network Relation of Li Shimeng

Insider Network Chart

Li Shimeng Owned Company Details

What does Simcere Pharmaceutical Group Ltd do?

Who are the key executives at Simcere Pharmaceutical Group Ltd?

Li Shimeng is the 2501 Other of Simcere Pharmaceutical Group Ltd. Other key executives at Simcere Pharmaceutical Group Ltd include 2501 Other Artking Global Limited , 2501 Other Fortune Fountain Investment Limited , and 2501 Other P&h Holdings Group Ltd. .

Simcere Pharmaceutical Group Ltd (HKSE:02096) Insider Trades Summary

Over the past 18 months, Li Shimeng made 4 insider transaction in Simcere Pharmaceutical Group Ltd (HKSE:02096) with a net sale of 0. Other recent insider transactions involving Simcere Pharmaceutical Group Ltd (HKSE:02096) include a net sale of 0 shares made by Ren Jinsheng , a net sale of 14,000,000 shares made by Artking Global Limited , and a net sale of 0 shares made by WANG Xi .

In summary, during the past 3 months, insiders sold 0 shares of Simcere Pharmaceutical Group Ltd (HKSE:02096) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,000,000 shares of Simcere Pharmaceutical Group Ltd (HKSE:02096) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,000,000 shares.

Simcere Pharmaceutical Group Ltd (HKSE:02096)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Simcere Pharmaceutical Group Ltd Insider Transactions

No Available Data

Li Shimeng Mailing Address

Above is the net worth, insider trading, and ownership report for Li Shimeng. Currently GuruFocus does not have mailing address information for Li Shimeng.